The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important ...
CNN: New menopause drug to target hot flashes without hormones gets FDA approval
The US Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday. The drug, ...
New menopause drug to target hot flashes without hormones gets FDA approval
Dracunculiasis (Guinea-worm disease) Drought Drowning Drugs (psychoactive) Earthquakes Ebola virus disease Echinococcosis
In the Anatomical Therapeutic Chemical (ATC) classification system, the active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties. Drugs are classified in groups at five different levels.
People who inject drugs are at increased risk of HIV, viral hepatitis C (HCV) and B (HBV), tuberculosis as well as overdose. Globally, around 11 million people inject drugs and around 1 in 8 (or 1.4 million) of them are living with HIV (UNODC World Drug Report, 2020) and 39.4% have viremic HCV infection.
AOL: FDA approves new menopause drug without hormones. Here's what to know.
The U.S. Food and Drug Administration has approved Lynkuet, a new daily pill from Bayer that provides a non-hormonal option for treating hot flashes, common during menopause. The drug, known ...